|The dengue virus non-structural 1 protein: risks and benefits|
JH Amorim, RP dos Santos Alves, SB Boscardin, LC de Souza Ferreira
Virus research 181, 53-60, 2014
|Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant|
JH Amorim, MO Diniz, FAMO Cariri, JF Rodrigues, RSP Bizerra, ...
Vaccine 30 (5), 837-845, 2012
|Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein|
JH Amorim, BFMM Porchia, A Balan, RCM Cavalcante, SM da Costa, ...
Journal of virological methods 167 (2), 186-192, 2010
|Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge|
HR Henriques, EV Rampazo, AJS Gonçalves, ECM Vicentin, JH Amorim, ...
PLoS Negl Trop Dis 7 (7), e2330, 2013
|Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action|
RD de Souza, MT Batista, WB Luiz, RCM Cavalcante, JH Amorim, ...
PLoS One 9 (1), e87454, 2014
|An improved extraction protocol for metagenomic DNA from a soil of the Brazilian Atlantic Rainforest|
JH Amorim, TNS Macena, GV Lacerda-Junior, RP Rezende, JCT Dias, ...
Genet Mol Res 7 (4), 1226-1232, 2008
|Functional diversity of heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli differential enzymatic and immunological activities of LT1 (hLT) AND LT4 (pLT)|
JF Rodrigues, C Mathias-Santos, ME Sbrogio-Almeida, JH Amorim, ...
Journal of Biological Chemistry 286 (7), 5222-5233, 2011
|A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice|
JH Amorim, RSP Bizerra, RP dos Santos Alves, ME Sbrogio-Almeida, ...
PLoS One 7 (9), e44984, 2012
|Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model|
JH Amorim, RP dos Santos Alves, R Bizerra, SA Pereira, LR Pereira, ...
Virology 487, 41-49, 2016
|In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations|
L dos Santos Franco, PO Vidal, JH Amorim
Journal of biomedical science 24 (1), 88, 2017
|Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen|
RP dos Santos Alves, LR Pereira, DLN Fabris, FS Salvador, RA Santos, ...
Clinical and Vaccine Immunology 23 (6), 460-469, 2016
|Role of bacteriophages in STEC infections: new implications for the design of prophylactic and treatment approaches|
JH Amorim, ME Del Cogliano, RJ Fernandez-Brando, MF Bilen, MR Jesus, ...
F1000Research 3, 2014
|Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T cell responses and …|
BFMM Porchia, MO Diniz, FAMO Cariri, VC Santana, JH Amorim, A Balan, ...
Molecular pharmaceutics 8 (6), 2320-2330, 2011
|Epitope sequences in dengue virus NS1 protein identified by monoclonal antibodies|
LB Rocha, RPS Alves, BA Caetano, LR Pereira, T Mitsunari, JH Amorim, ...
Antibodies 6 (4), 14, 2017
|Adjuvant-mediated epitope specificity and enhanced neutralizing activity of antibodies targeting dengue virus envelope protein|
DLNF Maeda, MT Batista, LR Pereira, M de Jesus Cintra, JH Amorim, ...
Frontiers in immunology 8, 1175, 2017
|Seeking Flavivirus cross-protective immunity|
L dos Santos Franco, LT Gushi, WB Luiz, JH Amorim
Frontiers in immunology 10, 2260, 2019
|Complete genome sequence of an atypical dengue virus serotype 2 lineage isolated in Brazil|
FS Salvador, JH Amorim, RPS Alves, SA Pereira, LCS Ferreira, ...
Genome announcements 3 (4), 2015
|A simple boiling-based DNA extraction for RAPD profiling of landfarm soil to provide representative metagenomic content|
JH Amorim, RO Vidal, GV Lacerda-Junior, JCT Dias, M Brendel, ...
Genetics and Molecular Research 11 (1), 182-189, 2012
|Dengue virus models based on mice as experimental hosts|
JH Amorim, R Bizerra, RP dos Santos Alves, DL Nascimento Fabris, ...
Future Virology 10 (7), 835-844, 2015
|Anti-dengue Vaccines: From Development to Clinical Trials|
JR Pinheiro-Michelsen, RSO Souza, IVR Santana, PS da Silva, ...
Frontiers in Immunology 11, 1252, 2020